MYMiao Yuan

Miao Yuan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miao Yuan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Miao

    Department of Pathology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu, 210029, People's Republic of China

    1 shared publication
  • Chun-Qing Yang

    Department of Pathology , The First Affiliated Hospital of Nanjing Medical University , Nanjing , P.R. China

    1 shared publication
  • Chun-Yi Jiang

    Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, China

    1 shared publication
  • Liang Hu

    Department of Pharmacology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China

    1 shared publication
  • Lin Wang

    Department of Orthodontics, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China

    1 shared publication
  • Yan-Jing Yang

    Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China; Department of Pediatric and Preventive Dentistry, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing 210029, Jiangsu Province, China

    1 shared publication

Latest Publications

  • Open Access

    Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK

    by Yan-Jing Yang, Liang Hu, Ye-Peng Xia, Chun-Yi Jiang, Chen Miao, Chun-Qing Yang, Miao Yuan, Lin Wang

    Glial activation and neuroinflammation in the spinal trigeminal nucleus (STN) play a pivotal role in the genesis and maintenance of trigeminal neuralgia (TN). Resveratrol, a natural compound from grape and red wine, has a potential anti-inflammatory effect. We hypothesized that resveratrol could significantly suppress neuroinflammation in the STN mediated by glial activation and further relieve TN. In this study, we evaluated whether resveratrol could alleviate trigeminal allodynia and explore the mechanism underlying the antinociceptive effect of resveratrol. Animals were orally injected with resveratrol after chronic constriction injury (CCI) of the infraorbital nerve. Mechanical thresholds of the affected whisker pad were measured to assess nociceptive behaviors. The STN was harvested to quantify the changing levels of p-NR1, p-PKC, TNF-α, and IL1-β by western blotting and detect the expression of calcitonin gene-related peptide (CGRP) and c-Fos by immunofluorescence. Glial activation was observed by immunofluorescence and western blotting. Mitogen-activated protein kinase (MAPK) phosphorylation in vivo and in vitro was examined by western blotting. We found that resveratrol significantly attenuated trigeminal allodynia dose-dependently and decreased the increased expression of CGRP and c-Fos in the STN. Additionally, resveratrol showed an inhibitory effect on CCI-evoked astrocyte and microglia activation and reduced production of pro-inflammatory cytokines in the STN. Furthermore, the antinociceptive effect of resveratrol was partially mediated by reduced phosphorylation of MAP kinases via adenosine monophosphate-activated protein kinase (AMPK) activation. AMPK activation in the STN glia via resveratrol has utility in the treatment of CCI-induced neuroinflammation and further implicates AMPK as a novel target for the attenuation of trigeminal neuralgia.